Literature DB >> 25443198

Multidrug resistant Fusarium keratitis.

P Antequera1, V Garcia-Conca2, C Martín-González1, V Ortiz-de-la-Tabla3.   

Abstract

CASE REPORT: We report a case of keratitis in a female contact lens wearer, who developed a deep corneal abscess. The culture of a corneal biopsy scraping was positive for multiresistant Fusarium solani. The patient has a complicated clinical course and failed to respond to local and systemic antifungal treatment, requiring eye enucleation.
CONCLUSION: Fusarium keratitis may progress to severe endophthalmitis. Clinical suspicion is paramount in order to start antifungal therapy without delay. Therapy is complex due to the high resistance of this organism to usual antifungal drugs.
Copyright © 2014 Sociedad Española de Oftalmología. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Contact lens; Endoftalmitis; Endophthalmitis; Fusarium solani; Keratitis; Lentes de contacto; Queratitis

Mesh:

Substances:

Year:  2014        PMID: 25443198     DOI: 10.1016/j.oftal.2014.04.008

Source DB:  PubMed          Journal:  Arch Soc Esp Oftalmol        ISSN: 0365-6691


  4 in total

1.  Multidrug-resistant Fusarium keratitis: diagnosis and treatment considerations.

Authors:  Sergio Sara; Kendall Sharpe; Sharon Morris
Journal:  BMJ Case Rep       Date:  2016-08-03

2.  Fusarium Keratitis in Germany.

Authors:  Grit Walther; Serena Stasch; Kerstin Kaerger; Axel Hamprecht; Mathias Roth; Oliver A Cornely; Gerd Geerling; Colin R Mackenzie; Oliver Kurzai; Marie von Lilienfeld-Toal
Journal:  J Clin Microbiol       Date:  2017-07-26       Impact factor: 5.948

3.  Killing of diverse eye pathogens (Acanthamoeba spp., Fusarium solani, and Chlamydia trachomatis) with alcohols.

Authors:  Yousuf Aqeel; Raquel Rodriguez; Aparajita Chatterjee; Robin R Ingalls; John Samuelson
Journal:  PLoS Negl Trop Dis       Date:  2017-02-09

Review 4.  Recent Advances in Photodynamic Therapy against Fungal Keratitis.

Authors:  Jia-Horung Hung; Chaw-Ning Lee; Huai-Wen Hsu; I-Son Ng; Chi-Jung Wu; Chun-Keung Yu; Nan-Yao Lee; Yun Chang; Tak-Wah Wong
Journal:  Pharmaceutics       Date:  2021-11-26       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.